Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a potent class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, enhancing https://peptidences.com/bio-genome-protein-drug